Brought to you by:
SoundBite peripheral crossing system gains FDA approval
Soundbite Medical Solutions has announced Food and Drug Administration (FDA) 510(k) approval for the SoundBite crossing system—Peripheral (SCS-P) with the 0.014” active wire (14P). The SoundBite crossing system—Peripheral (14P) is a recanalization tool, designed to help physician’s placement of conventional…
Peer-to-peer coaching program created to strengthen wellness support
The Society for Vascular Surgery (SVS) and the Academy for Surgical Coaching are developing a first-of-its-kind coaching program that strengthens wellness support for vascular surgeons. Studies show they—along with physicians across specialties—are experiencing an increase in burnout, anxiety, depression and…
VAM: Session on diversity set to feature on Friday of SVS annual meeting
Racial and ethnically based disparities exist in healthcare. To highlight these disparities, and what the Society for Vascular Surgery (SVS) is doing to address them, the 2021 Vascular Annual Meeting (VAM) will feature a special session on diversity, equity and…
Plans revealed for pilot study on performance of EVAR for AAA in office-based labs
Details of a planned pilot study investigating the merits of performing endovascular aortic repair (EVAR) on abdominal aortic aneurysms (AAAs) in office-based labs (OBLs) and other free-standing ambulatory facilities emerged during the recent Critical Issues America annual meeting (April 16–17)…
Registry data show EVAR is safe, durable and effective out to five years
Endovascular aortic repair (EVAR) is safe, durable and effective, the five-year interim results of the Global Registry for Endovascular Aortic Treatment (the GREAT registry) show. In this analysis of more than 3,000 abdominal aortic aneurysm (AAA) patients treated with an…
SVS seeks nominees for prestigious community practice award by May 1
The Society for Vascular Surgery (SVS) is on the lookout for candidates for the next Excellence in Community Service Award, with the deadline for submissions falling on May 1. The accolade is bestowed on an SVS member who has exhibited…
PAD: Endologix acquires PQ Bypass
Endologix recently announced completing the acquisition of PQ Bypass, a medical technology company pioneering a first-of-its-kind technology that addresses severe peripheral arterial disease (PAD). PQ Bypass’ proprietary Detour platform for percutaneous femoropopliteal bypass has been designated by the Food and…
Surgeons react to reintroduction of bill that aims to increase access to PAD screening
The recent reintroduction of the bipartisan Amputation Reduction and Compassion (ARC) Act—aimed at improving peripheral arterial disease (PAD) education, increasing access to PAD screening and preventing avoidable lower limb amputations—has drawn a mixed response from vascular surgeons. The move gained…
VenoValve: Chronic venous insufficiency device gains brisk double of first US patent, IDE approval
Hancock Jaffe Laboratories recently revealed that the United States Patent and Trademark Office (USPTO) issued the first patent covering the company’s VenoValve. The patent is entitled Implantable Vein Frame and is U.S. patent number 10,959,841. The company recently announced that only…
Emerging picture: VAM 2021 shaping up into blockbuster event
The moving pieces that comprise the 2021 Vascular Annual Meeting (VAM), set to take place Aug. 18–21 at the San Diego Convention Center, San Diego, California, are being assembled into a blockbuster whole. Though plenary sessions have yet to be…